Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Reiteration

Reiteration

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Rosenblatt Reiterates Buy on Bentley Systems, Maintains $39 Price Target

By Benzinga Newsdesk
February 28, 8:23 AM
Rosenblatt analyst Blair Abernethy reiterates Bentley Systems (NASDAQ:BSY) with a Buy and maintains $39 price target.

BSY

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

HC Wainwright & Co. Reiterates Buy on Clene, Maintains $15 Price Target

By Benzinga Newsdesk
February 28, 7:55 AM
HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $15 price target.

CLNN

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Mizuho Reiterates Buy on Zoom Video Comms, Maintains $100 Price Target

By Benzinga Newsdesk
February 28, 7:37 AM
Mizuho analyst Siti Panigrahi reiterates Zoom Video Comms (NASDAQ:ZM) with a Buy and maintains $100 price target.

ZM

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Jefferies Reiterates Buy on Frontline, Maintains $22 Price Target

By Benzinga Newsdesk
February 28, 7:24 AM
Jefferies analyst Omar Nokta reiterates Frontline (NYSE:FRO) with a Buy and maintains $22 price target.

FRO

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Needham Reiterates Buy on Workday, Maintains $220 Price Target

By Benzinga Newsdesk
February 28, 7:13 AM
Needham analyst Scott Berg reiterates Workday (NASDAQ:WDAY) with a Buy and maintains $220 price target.

WDAY

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Needham Reiterates Buy on Magnite, Maintains $15 Price Target

By Benzinga Newsdesk
February 28, 6:44 AM
Needham analyst Laura Martin reiterates Magnite (NASDAQ:MGNI) with a Buy and maintains $15 price target.

MGNI

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Chardan Capital Reiterates Buy on Li-Cycle Holdings, Maintains $10 Price Target

By Benzinga Newsdesk
February 28, 5:42 AM
Chardan Capital analyst Brian Dobson reiterates Li-Cycle Holdings (NYSE:LICY) with a Buy and maintains $10 price target.

LICY

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Chardan Capital Reiterates Buy on uniQure, Maintains $60 Price Target

By Benzinga Newsdesk
February 28, 5:41 AM
Chardan Capital analyst Matthew Barcus reiterates uniQure (NASDAQ:QURE) with a Buy and maintains $60 price target.

QURE

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Chardan Capital Reiterates Buy on Krystal Biotech, Maintains $133 Price Target

By Benzinga Newsdesk
February 28, 5:39 AM
Chardan Capital analyst Geulah Livshits reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and maintains $133 price target.

KRYS

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Piper Sandler Reiterates Overweight on EPAM Sys, Maintains $391 Price Target

By Benzinga Newsdesk
February 28, 5:35 AM
Piper Sandler analyst Arvind Ramnani reiterates EPAM Sys (NYSE:EPAM) with a Overweight and maintains $391 price target.

EPAM

Posts pagination

Previous 1 … 275 276 277 … 399 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service